NCT06169709

Brief Summary

The goal of this exploratory study following a cross-sectional online survey in women with ADHD is to

  1. 1.describe overall experiences regarding ADHD symptoms, diagnosis, treatment, sources of support, and any perceived barriers on those domains;
  2. 2.determine which life domains are most affected by ADHD symptoms;
  3. 3.calculate the prevalence of reported health conditions within the following domains: circulatory system, endocrine or metabolic system, gastrointestinal system, genitourinary system, musculoskeletal system, nervous system, respiratory system, skin, reproductive system, cancer, psychiatric conditions, COVID-19, sensory sensitivity, menstrual cycle, and sleep;
  4. 4.identify topics that women with ADHD would like to see studied in future research.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,893

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 13, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

February 20, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2025

Completed
Last Updated

July 18, 2025

Status Verified

July 1, 2025

Enrollment Period

1.4 years

First QC Date

December 4, 2023

Last Update Submit

July 15, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • To describe the overall experiences, thoughts, and perspectives of women with ADHD, including domains of ADHD diagnosis and symptoms, ADHD and other health conditions, menstrual cycle, conflict tactics and romantic relationships, and sleep.

    A self-developed questionnaire. The sections on demographic information, ADHD diagnosis, ADHD diagnosis \& symptoms and menstrual cycles are constructed for the purpose of this survey. Moreover, the questionnaire contains sections from the Ultrashort screener for adult ADHD, the Holland Sleep Disorder Questionnaire and the Conflict Tactics scale 2.

    50 minutes

Secondary Outcomes (1)

  • To identify topics for further research and ways of improving healthcare (e.g. the diagnostic process or effective treatment) for women with ADHD

    50 minutes

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsIndividuals who identify as women.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The survey is aimed at women (or people who identify as women) over 18 years with ADHD (both self-diagnosed and diagnosed by a health professional).

You may qualify if:

  • Identify as a woman
  • Aged 18 or above
  • Have ADHD (both diagnosed by a health professional and self-diagnosed)

You may not qualify if:

  • People who are not able to read, understand, or sign the information letter or informed consent form are excluded from participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Parnassia Groep

The Hague, Netherlands

Location

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Officials

  • Sandra Kooij, Prof. dr.

    PsyQ

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

December 4, 2023

First Posted

December 13, 2023

Study Start

February 20, 2024

Primary Completion

July 10, 2025

Study Completion

July 10, 2025

Last Updated

July 18, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations